# Relmada Therapeutics, Inc.: Form 8-K/A, filed Apr 6, 2020

- Company: [Relmada Therapeutics, Inc.](/companies/rlmd.md) (CIK 1553643)
- Form: 8-K/A
- Filed: 2020-04-06
- Accepted by EDGAR: Apr 6, 2020, 16:30 ET
- Period: 2020-03-06
- Accession: 0001213900-20-008650
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1553643/000121390020008650/ea120418-8ka_relmada.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1553643/000121390020008650/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1553643/000121390020008650/ea120418-8ka_relmada.htm

Filed Apr 6, 2020.
Source: SEC EDGAR, the filing index for accession 0001213900-20-008650. Last ingested by Listed: Nov 13, 2026, 15:42 ET. No prices; not investment advice.
